Armata (ARMP) CEO Deborah Birx Shares Withheld for Taxes

What Happened
Deborah Birx, CEO of Armata Pharmaceuticals (ARMP), had 14,041 shares withheld by the company on July 10, 2026 to satisfy tax and withholding obligations related to the net settlement of restricted stock units (RSUs). The withheld shares were valued at $4.26 each, totaling $59,815. This was a tax withholding/net settlement of awards—not an open-market sale by the insider.

Key Details

• Transaction date: July 10, 2026; Filing date: July 14, 2026 (filed within the normal Form 4 timeframe).
• Shares withheld/disposed: 14,041 shares at $4.26 per share; total value ≈ $59,815.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Transaction code: F — tax withholding in connection with net settlement of RSUs.
• Footnote: F1 — Company withheld shares to satisfy its income tax and withholding remittance obligations related to net settlement of restricted stock units.

Context
This is a routine withholding of shares to cover taxes on vested RSUs and does not necessarily reflect buying or selling intent by the insider. Tax-withholding dispositions are common following awards or vesting events and are treated differently from open-market sales when interpreting insider sentiment.